Literature DB >> 21401950

Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma.

Danny C W Yu1, Jonathan P Bury, James Tiernan, Jennifer S Waby, Carolyn A Staton, Bernard M Corfe.   

Abstract

BACKGROUND: Previous reports have suggested that the VEGF receptor neuropilin-1 (NRP-1) is expressed in a singly dispersed subpopulation of cells in the normal colonic epithelium, but that expression becomes dysregulated during colorectal carcinogenesis, with higher levels in tumour suggestive of a poor prognosis. We noted that the spatial distribution and morphology if NRP-1 expressing cells resembles that of enteroendocrine cells (EEC) which are altered in response to disease state including cancer and irritable bowel syndrome (IBS). We have shown that NRP-1 is down-regulated by butyrate in colon cancer cell lines in vitro and we hypothesized that butyrate produced in the lumen would have an analogous effect on the colon mucosa in vivo. Therefore we sought to investigate whether NRP-1 is expressed in EEC and how NRP-1 and EEC respond to butyrate and other short-chain fatty acids (SCFA - principally acetate and propionate). Additionally we sought to assess whether there is a field effect around adenomas.
METHODOLOGY: Biopsies were collected at the mid-sigmoid, at the adenoma and at the contralateral wall (field) of 28 subjects during endoscopy. Samples were fixed for IHC and stained for either NRP-1 or for chromogranin A (CgA), a marker of EEC. Stool sampling was undertaken to assess individuals' butyrate, acetate and propionate levels. RESULT: NRP-1 expression was inversely related to SCFA concentration at the colon landmark (mid-sigmoid), but expression was lower and not related to SCFA concentration at the field. Likewise CgA+ cell number was also inversely related to SCFA at the landmark, but was lower and unresponsive at the field. Crypt cellularity was unaltered by field effect. A colocalisation analysis showed only a small subset of NRP-1 localised with CgA. Adenomas showed extensive, weaker staining for NRP-1 which contrastingly correlated positively with butyrate level. Field effects cause this relationship to be lost. Adenoma tissue shows dissociation of the co-regulation of NRP-1 and EEC.
CONCLUSION: NRP-1 is inversely associated with levels of butyrate and other SCFA in vivo and is expressed in a subset of CgA expressing cells. EEC number is related to butyrate level in the same way.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401950      PMCID: PMC3068125          DOI: 10.1186/1476-4598-10-27

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


  39 in total

Review 1.  Vascular endothelial growth factor signaling pathways: therapeutic perspective.

Authors:  Marcin Kowanetz; Napoleone Ferrara
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

2.  Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia.

Authors:  Abigael C J Polley; Francis Mulholland; Carmen Pin; Elizabeth A Williams; D Mike Bradburn; Sarah J Mills; John C Mathers; Ian T Johnson
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

3.  Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway.

Authors:  V Medina; B Edmonds; G P Young; R James; S Appleton; P D Zalewski
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

4.  Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.

Authors:  R Pili; M P Kruszewski; B W Hager; J Lantz; M A Carducci
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Changes in serotonin dynamics in the gastrointestinal tract of colon-26 tumour-bearing mice: effects of cisplatin treatment.

Authors:  Y Nitta; M Nishibori; H Iwagaki; T Yoshino; S Mori; K Sawada; N Nakaya; K Saeki; N Tanaka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-10       Impact factor: 3.000

Review 6.  Butyrate and the colonocyte. Implications for neoplasia.

Authors:  O C Velázquez; H M Lederer; J L Rombeau
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

Review 7.  Will mandatory folic acid fortification prevent or promote cancer?

Authors:  Young-In Kim
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

8.  Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme.

Authors:  Ulrike Peters; Rashmi Sinha; Nilanjan Chatterjee; Amy F Subar; Regina G Ziegler; Martin Kulldorff; Robert Bresalier; Joel L Weissfeld; Andrew Flood; Arthur Schatzkin; Richard B Hayes
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

9.  Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.

Authors:  Danny C W Yu; Jennifer S Waby; Haridasan Chirakkal; Carolyn A Staton; Bernard M Corfe
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

10.  Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets.

Authors:  Byung-Ju Kim; Kwang-Hyun Park; Chang-Yeol Yim; Shin Takasawa; Hiroshi Okamoto; Mie-Jae Im; Uh-Hyun Kim
Journal:  Diabetes       Date:  2008-01-09       Impact factor: 9.461

View more
  9 in total

1.  A mathematical model of the colon crypt capturing compositional dynamic interactions between cell types.

Authors:  Kieran Smallbone; Bernard M Corfe
Journal:  Int J Exp Pathol       Date:  2013-12-20       Impact factor: 1.925

Review 2.  Neuropilins: expression and roles in the epithelium.

Authors:  Jonathan R L Wild; Carolyn A Staton; Keith Chapple; Bernard M Corfe
Journal:  Int J Exp Pathol       Date:  2012-04       Impact factor: 1.925

3.  Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19.

Authors:  Ikram Omar Osman; Clémence Garrec; Gabriel Augusto Pires de Souza; Ana Zarubica; Djamal Brahim Belhaouari; Jean-Pierre Baudoin; Hubert Lepidi; Jean-Louis Mege; Bernard Malissen; Bernard La Scola; Christian Albert Devaux
Journal:  Front Cell Infect Microbiol       Date:  2022-05-04       Impact factor: 6.073

Review 4.  Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer.

Authors:  Mridul Sharma; Geeta Shukla
Journal:  Front Microbiol       Date:  2016-12-02       Impact factor: 5.640

Review 5.  Lipid metabolism reprogramming and its potential targets in cancer.

Authors:  Chunming Cheng; Feng Geng; Xiang Cheng; Deliang Guo
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

Review 6.  Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer.

Authors:  Xinqiang Wu; Yuanbing Wu; Liangmei He; Longhuo Wu; Xiangcai Wang; Zhiping Liu
Journal:  J Cancer       Date:  2018-06-15       Impact factor: 4.207

7.  Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.

Authors:  Wei Zhu; Yan Si; Jun Xu; Yu Lin; Jing-Zi Wang; Mengda Cao; Shanwen Sun; Qiang Ding; Lingjun Zhu; Ji-Fu Wei
Journal:  J Cell Mol Med       Date:  2020-02-10       Impact factor: 5.310

Review 8.  Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota.

Authors:  Yean Leng Loke; Ming Tsuey Chew; Yun Fong Ngeow; Wendy Wan Dee Lim; Suat Cheng Peh
Journal:  Front Cell Infect Microbiol       Date:  2020-12-08       Impact factor: 5.293

9.  The effect of FTO rs9939609 polymorphism on the association between colorectal cancer and dietary fiber.

Authors:  Soroor Fathi; Mina Ahmadzadeh; Mahsa Vahdat; Maryam Afsharfar; Zahra Roumi; Naeemeh Hassanpour Ardekanizadeh; Soheila Shekari; Seyed Mohammad Poorhosseini; Maryam Gholamalizadeh; Sepideh Abdollahi; Elham Kheyrani; Saeid Doaei
Journal:  Front Nutr       Date:  2022-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.